Cleo Diagnostics

Follow
Get notifications in MyBN when activity occurs.
Subscribe to BN Log In

Cleo Diagnostics is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer.

Contact Details

Level 2, 480 Collins Street , MELBOURNE VIC 3000
cleodx.com

Lists and Charts

Share price

Cleo Diagnostics
Closing price for the last 90 trading days
View ASX Chart
Powered by Morningstar ®

Total Shareholder Return as at 02/12/24

Rank Company 1 Yr 5 Yr
125th MyATM Holdings 106.56% 42.81%
126th Arovella Therapeutics 106.52% 24.31%
127th Cleo Diagnostics 106.06% 0%
128th Terragen Holdings 105.56% 0%
129th Bravura Solutions 105.34% -19.16%
View Full List
1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

  • Company Activity

    		 NEW ROLE: Lucinda Nolan, Non-Executive Director 17 Jul 2024
    		NEW ROLE: Richard Allman, Chief Executive Officer, Executive Director 17 Jul 2024
    		NEW ROLE: Andrew Stephens, Chief Scientific Officer, Executive Director 17 Jul 2024

Related Information

Access to our data for Cleo Diagnostics is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Cleo Diagnostics is included in 1 list - Public Companies - non WA.

For public companies, our subscribers have access to the list of executives and directors along with company financials, director's interests and remuneration.

Subscribe today